BIOS
BioPlus Acquisition Corp.
Set alert
10.80 0.00 0.00%
10.79 Day range 10.80
52-week range unavailable
- Open
- 10.80
- Prev close
- 10.80
- Mkt cap
- 209.07M
- Vol
- 5.64K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.79
- High
- 10.80
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.11
- Inst. own
- 167.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 20, 2020
- 50-d avg
- 10.77
- 200-d avg
- 10.55
- 1y target
- 20.00
Key statistics
- Market cap
- 209.07M
- Enterprise value
- 215.74M
- Trailing P/E
- 51.40
- Forward P/E
- 0.00
- PEG ratio
- -7.93
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.21
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -958.04K
- Total cash
- 2.45K
- Total debt
- 6.57M
- Return on equity
- 0.00%
- Shares outstanding
- 19.37M
- Short % of float
- 0.01%
- 50-day average
- 10.77
- 200-day average
- 10.55
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 20.00 +85.3% upside
Now 10.80
- Target (low)
- 16.00
- Target (mean)
- 20.00
- Target (high)
- 23.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy3
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Mar 20, 2020
Expected Mar 20, 2020. Consensus EPS estimate -0.09.
Financials — quick view
BIOS Revenue — quarterly 0
BIOS Net income — quarterly 1.24M
BIOS EPS — quarterly 0.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 20, 2020 | Dec 1, 2019 | -0.01 | — | — | — |
| Nov 6, 2019 | Sep 1, 2019 | -0.01 | — | — | — |
| Jul 30, 2019 | Jun 1, 2019 | -0.10 | — | — | — |
| May 2, 2019 | Mar 1, 2019 | -0.12 | — | — | — |
| Mar 15, 2019 | Dec 1, 2018 | -0.03 | — | — | — |
| Nov 6, 2018 | Sep 1, 2018 | -0.07 | — | — | — |
About BioPlus Acquisition Corp.
BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
- Website
- bioplusspac.com
News
- COMPUTEX 2026: MiTAC Advances Diversified AI Infrastructure Through Strategic Ecosystem Partnerships
- BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate
- Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation
- BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering
- Option Care Health Completes Reverse Stock Split and Ticker Symbol Change
- Stocks That Hit 52-Week Highs On Tuesday
- Stocks That Hit 52-Week Highs On Friday
- Stocks That Hit 52-Week Highs On Thursday
- Stocks That Hit 52-Week Highs On Thursday
- Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment
Your note
Sign in to keep a note on BIOS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BIOPLUS SPONSOR ,LLC | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jun 4, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Westchester Capital Management, LLC | 10.21% | 1,390,000 | 14.80M | Jun 29, 2023 |
| First Trust Capital Management L.P. | 8.12% | 1,106,378 | 11.78M | Jun 29, 2023 |
| Mizuho Securities USA LLC | 7.45% | 1,014,334 | 10.80M | Jun 29, 2023 |
| Linden Advisors LP | 7.34% | 1,000,000 | 10.65M | Jun 29, 2023 |
| Radcliffe Capital Management, L.P. | 5.28% | 718,747 | 7.65M | Jun 29, 2023 |
| Berkley W R Corp | 4.39% | 597,631 | 6.36M | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Merger Fund, The | 8.22% | 1,119,976 | 11.93M | Jun 29, 2023 |
| Investment Managers Ser Tr II-First Trust Merger Arbitrage Fd | 7.76% | 1,056,378 | 11.25M | Jun 29, 2023 |
| WCM Alternatives Event Driven Fd | 0.59% | 80,049 | 852.52K | Jun 29, 2023 |
| Saba Capital Income & Opportunities Fd | 0.58% | 78,809 | 843.26K | Jul 30, 2023 |
| JNL Series Trust-JNL/Multi Manager Alternative Fund | 0.57% | 77,112 | 821.24K | Jun 29, 2023 |
| Merger Fund Vl, The | 0.29% | 39,856 | 424.47K | Jun 29, 2023 |